PortfoliosLab logoPortfoliosLab logo
NVO vs. ENOG.L
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NVO vs. ENOG.L - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novo Nordisk A/S (NVO) and Energean Oil & Gas plc (ENOG.L). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

NVO is traded in USD, while ENOG.L is traded in GBp. To make them comparable, the ENOG.L values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, NVO achieves a -10.74% return, which is significantly higher than ENOG.L's -13.52% return.


NVO

1D
-0.18%
1M
-6.80%
YTD
-10.74%
6M
-9.50%
1Y
-43.34%
3Y*
-15.59%
5Y*
2.92%
10Y*
7.56%

ENOG.L

1D
-1.29%
1M
-13.95%
YTD
-13.52%
6M
-12.98%
1Y
-7.45%
3Y*
-2.07%
5Y*
4.97%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

NVO vs. ENOG.L - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
NVO
Novo Nordisk A/S
-10.74%-39.22%-15.93%54.84%22.66%63.52%23.33%28.70%-7.31%
ENOG.L
Energean Oil & Gas plc
-13.52%0.92%6.58%-6.54%43.05%17.48%-20.08%53.96%26.43%

Correlation

The correlation between NVO and ENOG.L is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.00

Correlation (5Y)
Calculated over the trailing 5-year period

0.01

Correlation (All Time)
Calculated using the full available price history since Mar 16, 2018

0.04

Fundamentals

Market Cap

NVO:

$195.21B

ENOG.L:

£1.37B

EPS

NVO:

DKK 27.42

ENOG.L:

-$1.94

PS Ratio

NVO:

3.85

ENOG.L:

0.75

PB Ratio

NVO:

6.21

ENOG.L:

12.95

Total Revenue (TTM)

NVO:

DKK 327.80B

ENOG.L:

$2.45B

Gross Profit (TTM)

NVO:

DKK 268.30B

ENOG.L:

$811.30M

EBITDA (TTM)

NVO:

DKK 181.54B

ENOG.L:

$1.42B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NVO vs. ENOG.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVO
NVO Risk / Return Rank: 1212
Overall Rank
NVO Sharpe Ratio Rank: 99
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 1212
Sortino Ratio Rank
NVO Omega Ratio Rank: 1010
Omega Ratio Rank
NVO Calmar Ratio Rank: 1212
Calmar Ratio Rank
NVO Martin Ratio Rank: 1616
Martin Ratio Rank

ENOG.L
ENOG.L Risk / Return Rank: 3232
Overall Rank
ENOG.L Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
ENOG.L Sortino Ratio Rank: 2929
Sortino Ratio Rank
ENOG.L Omega Ratio Rank: 2929
Omega Ratio Rank
ENOG.L Calmar Ratio Rank: 3636
Calmar Ratio Rank
ENOG.L Martin Ratio Rank: 3333
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVO vs. ENOG.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and Energean Oil & Gas plc (ENOG.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NVOENOG.LDifference
Sharpe ratioReturn per unit of total volatility

-0.58

Sortino ratioReturn per unit of downside risk

-0.88

Omega ratioGain probability vs. loss probability

0.85

0.98

-0.13

Calmar ratioReturn relative to maximum drawdown

-0.80

-0.31

-0.49

Martin ratioReturn relative to average drawdown

-1.18

-0.81

-0.37

NVO vs. ENOG.L - Sharpe Ratio Comparison

The current NVO Sharpe Ratio is -0.84, which is lower than the ENOG.L Sharpe Ratio of -0.26. The chart below compares the historical Sharpe Ratios of NVO and ENOG.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NVO vs. ENOG.L - Drawdown Comparison

The maximum NVO drawdown since its inception was -74.70%, roughly equal to the maximum ENOG.L drawdown of -73.57%. Use the drawdown chart below to compare losses from any high point for NVO and ENOG.L.


Loading charts...

Drawdown Indicators


NVOENOG.LDifference

Max Drawdown

Largest peak-to-trough decline

-74.70%

-73.57%

-1.13%

Max Drawdown (1Y)

Largest decline over 1 year

-54.34%

-24.22%

-30.12%

Max Drawdown (3Y)

Largest decline over 3 years

-74.70%

-33.29%

-41.41%

Max Drawdown (5Y)

Largest decline over 5 years

-74.70%

-40.56%

-34.14%

Max Drawdown (10Y)

Largest decline over 10 years

-74.70%

Current Drawdown

Current decline from peak

-68.11%

-22.80%

-45.31%

Average Drawdown

Average peak-to-trough decline

-17.79%

-15.77%

-2.02%

Ulcer Index

Depth and duration of drawdowns from previous peaks

37.62%

9.22%

+28.40%

Volatility

NVO vs. ENOG.L - Volatility Comparison

Novo Nordisk A/S (NVO) has a higher volatility of 10.68% compared to Energean Oil & Gas plc (ENOG.L) at 8.66%. This indicates that NVO's price experiences larger fluctuations and is considered to be riskier than ENOG.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NVOENOG.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.68%

8.66%

+2.02%

Volatility (6M)

Calculated over the trailing 6-month period

38.04%

22.00%

+16.04%

Volatility (1Y)

Calculated over the trailing 1-year period

51.88%

28.95%

+22.93%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

38.33%

38.49%

-0.16%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.56%

46.88%

-14.32%

Dividends

NVO vs. ENOG.L - Dividend Comparison

NVO's dividend yield for the trailing twelve months is around 4.11%, less than ENOG.L's 9.99% yield.


PositionTTM20252024202320222021202020192018201720162015
ENOG.L
Energean Oil & Gas plc
9.99%10.16%7.89%11.49%4.58%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVO
Novo Nordisk A/S
4.11%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%

Financials

NVO vs. ENOG.L - Financials Comparison

This section allows you to compare key financial metrics between Novo Nordisk A/S and Energean Oil & Gas plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B20222023202420252026
96.82B
928.78M
(NVO) Total Revenue
(ENOG.L) Total Revenue
Please note, different currencies. NVO values in DKK, ENOG.L values in USD

NVO vs. ENOG.L - Profitability Comparison

The chart below illustrates the profitability comparison between Novo Nordisk A/S and Energean Oil & Gas plc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%90.0%20222023202420252026
86.0%
23.8%
Portfolio components
NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

ENOG.L - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Energean Oil & Gas plc reported a gross profit of 221.43M and revenue of 928.78M. Therefore, the gross margin over that period was 23.8%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

ENOG.L - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Energean Oil & Gas plc reported an operating income of 195.15M and revenue of 928.78M, resulting in an operating margin of 21.0%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.

ENOG.L - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Energean Oil & Gas plc reported a net income of -369.83M and revenue of 928.78M, resulting in a net margin of -39.8%.


Frequently Asked Questions


NVO and ENOG.L have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for NVO and ENOG.L

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer